Index RUT
P/E -
EPS (ttm) -1.47
Insider Own 64.18%
Shs Outstand 14.64M
Perf Week -2.62%
Market Cap 141.77M
Forward P/E -
EPS next Y -1.52
Insider Trans 2.05%
Shs Float 6.20M
Perf Month -0.61%
Income -22.33M
PEG -
EPS next Q -0.39
Inst Own 7.38%
Short Float / Ratio 5.57% / 7.87
Perf Quarter -40.26%
Sales 0.00M
P/S -
EPS this Y 5.83%
Inst Trans 29.42%
Short Interest 0.35M
Perf Half Y -54.04%
Book/sh 0.96
P/B 8.50
EPS next Y -7.03%
ROA -94.78%
Target Price 20.67
Perf Year 7.20%
Cash/sh 1.27
P/C 6.43
EPS next 5Y -
ROE -120.53%
52W Range 7.14 - 18.65
Perf YTD 9.20%
Dividend -
P/FCF -
EPS past 5Y -
ROI -133.85%
52W High -56.09%
Beta 0.19
Dividend % -
Quick Ratio 3.99
Sales past 5Y 0.00%
Gross Margin -
52W Low 14.71%
ATR 0.65
Employees 11
Current Ratio 3.99
Sales Q/Q -
Oper. Margin 0.00%
RSI (14) 40.77
Volatility 5.32% 7.61%
Optionable No
Debt/Eq 0.00
EPS Q/Q 12.69%
Profit Margin -
Rel Volume 1.13
Prev Close 8.44
Shortable Yes
LT Debt/Eq 0.00
Earnings Nov 08 BMO
Payout -
Avg Volume 43.90K
Price 8.19
Recom 1.00
SMA20 -0.87%
SMA50 -11.54%
SMA200 -38.16%
Volume 49,673
Change -2.96%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-13-22 Initiated
Ladenburg Thalmann
Buy
$21
Nov-08-23 08:00AM
Oct-24-23 08:00AM
Oct-16-23 09:35AM
Sep-25-23 07:30PM
Sep-21-23 08:00AM
08:00AM
Loading…
Sep-12-23 08:00AM
Sep-06-23 08:00AM
Sep-01-23 08:00AM
Aug-17-23 08:00AM
Aug-11-23 07:01AM
Aug-10-23 06:24AM
Aug-09-23 08:00AM
06:26AM
Aug-08-23 06:28AM
Aug-07-23 06:35AM
07:14AM
Loading…
Aug-04-23 07:14AM
Aug-03-23 07:15AM
Aug-02-23 07:52AM
Aug-01-23 06:51AM
06:51AM
Jul-31-23 06:44AM
Jul-28-23 07:58AM
07:58AM
Jul-27-23 07:10AM
Jul-26-23 01:12PM
Jul-25-23 07:16AM
07:16AM
Jul-24-23 07:12AM
Jul-21-23 07:23AM
07:23AM
06:55AM
Loading…
Jul-20-23 06:55AM
06:55AM
Jul-19-23 07:10AM
07:10AM
Jul-18-23 06:53AM
Jul-17-23 07:10AM
Jul-14-23 06:50AM
06:50AM
Jul-13-23 07:02AM
07:02AM
Jul-12-23 07:22AM
Jul-11-23 06:08AM
06:08AM
Jul-10-23 06:56AM
06:56AM
Jul-05-23 06:46AM
Jul-03-23 06:50AM
Jun-30-23 06:52AM
Jun-29-23 06:49AM
Jun-28-23 07:13AM
06:58AM
Jun-27-23 06:46AM
06:46AM
Jun-26-23 06:41AM
Jun-21-23 07:20AM
Jun-20-23 08:00AM
06:35AM
Jun-18-23 08:03AM
Jun-05-23 08:50AM
Jun-01-23 04:48AM
May-31-23 06:22AM
May-19-23 08:50AM
May-15-23 09:55AM
08:00AM
May-10-23 08:00AM
May-09-23 01:34PM
May-02-23 06:46AM
May-01-23 06:45AM
Apr-28-23 07:04AM
Apr-27-23 10:14AM
08:00AM
06:47AM
Apr-26-23 06:26AM
Apr-20-23 07:03AM
Apr-19-23 06:53AM
Apr-18-23 08:00AM
Apr-17-23 06:54AM
Apr-14-23 06:37AM
Apr-13-23 06:52AM
Apr-12-23 07:07AM
Apr-11-23 06:58AM
Apr-10-23 08:00AM
06:44AM
Apr-07-23 07:44AM
Apr-06-23 07:20AM
Apr-05-23 07:19AM
06:11AM
Apr-04-23 07:08AM
Apr-03-23 06:48AM
Mar-31-23 06:36AM
Mar-30-23 06:36AM
Mar-29-23 06:32AM
Mar-17-23 08:00AM
Mar-10-23 08:00AM
Mar-09-23 05:29AM
Mar-07-23 08:00AM
Feb-23-23 08:00AM
Feb-16-23 07:28AM
Feb-15-23 07:01AM
Feb-10-23 06:42AM
Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product pipeline includes NXP800 and NXP900. The company was founded by Ron Bentsur, Enrique Poradosu and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
BENTSUR RON Chairman & CEO Oct 10 Buy 11.08 640 7,091 3,237,484 Oct 12 04:05 PM BENTSUR RON Chairman & CEO Oct 09 Buy 11.19 830 9,288 3,236,844 Oct 10 08:30 AM BENTSUR RON Chairman & CEO Oct 06 Buy 11.27 250 2,818 3,236,014 Oct 10 08:30 AM BENTSUR RON Chairman & CEO Oct 05 Buy 11.09 1,400 15,526 3,235,764 Oct 06 08:37 AM BENTSUR RON Chairman & CEO Oct 04 Buy 10.95 1,820 19,929 3,234,364 Oct 06 08:37 AM BENTSUR RON Chairman & CEO Aug 16 Buy 15.15 115 1,742 3,232,544 Aug 16 04:05 PM BENTSUR RON Chairman & CEO Aug 15 Buy 14.34 235 3,370 3,232,429 Aug 16 04:05 PM BENTSUR RON Chairman & CEO Aug 11 Buy 14.66 180 2,639 3,232,194 Aug 11 06:07 PM BENTSUR RON Chairman & CEO Aug 08 Buy 14.83 120 1,780 3,232,014 Aug 11 06:07 PM Mosseri Marlio Charles 10% Owner Jul 31 Buy 13.88 860 11,937 2,595,000 Aug 01 08:00 AM Mosseri Marlio Charles 10% Owner Jul 28 Buy 13.91 2,584 35,943 2,594,140 Jul 31 08:00 AM Mosseri Marlio Charles 10% Owner Jul 27 Buy 13.98 1,556 21,753 2,591,556 Jul 28 08:00 AM Mosseri Marlio Charles 10% Owner Jul 26 Buy 13.97 10,000 139,700 2,590,000 Jul 27 06:52 AM Mosseri Marlio Charles 10% Owner Jul 21 Buy 14.61 2,844 41,551 2,580,000 Jul 24 04:45 PM BENTSUR RON Chairman & CEO Jul 21 Buy 14.85 225 3,341 3,231,894 Jul 24 04:45 PM Mosseri Marlio Charles 10% Owner Jul 20 Buy 14.40 5,394 77,674 2,577,156 Jul 24 04:45 PM BENTSUR RON Chairman & CEO Jul 20 Buy 15.06 110 1,657 3,231,669 Jul 24 04:45 PM Mosseri Marlio Charles 10% Owner Jul 19 Buy 14.84 8,000 118,720 2,571,762 Jul 20 06:30 AM BENTSUR RON Chairman & CEO Jul 19 Buy 14.33 200 2,866 3,231,559 Jul 20 06:30 AM Mosseri Marlio Charles 10% Owner Jul 18 Buy 14.84 9,149 135,771 2,563,762 Jul 19 08:06 AM BENTSUR RON Chairman & CEO Jul 14 Buy 15.03 150 2,254 3,231,359 Jul 18 08:34 AM Mosseri Marlio Charles 10% Owner Jul 12 Buy 15.09 3,285 49,571 2,554,613 Jul 13 08:30 AM Mosseri Marlio Charles 10% Owner Jul 11 Buy 15.36 10,000 153,600 2,551,328 Jul 12 08:30 AM Mosseri Marlio Charles 10% Owner Jul 07 Buy 15.19 8,948 135,920 2,541,328 Jul 10 08:00 AM BENTSUR RON Chairman & CEO Jul 07 Buy 16.19 110 1,781 3,231,209 Jul 18 08:34 AM Mosseri Marlio Charles 10% Owner Jul 06 Buy 15.01 3,179 47,717 2,532,380 Jul 07 08:04 AM BENTSUR RON Chairman & CEO Jul 06 Buy 14.88 320 4,762 3,231,099 Jul 07 08:03 AM Mosseri Marlio Charles 10% Owner Jul 05 Buy 15.52 1,176 18,252 2,529,201 Jul 06 07:45 AM Mosseri Marlio Charles 10% Owner Jun 26 Buy 16.46 16,760 275,870 2,528,025 Jun 27 08:45 AM BENTSUR RON Chairman & CEO Jun 26 Buy 16.50 750 12,375 3,230,779 Jun 27 08:45 AM Mosseri Marlio Charles 10% Owner Jun 23 Buy 17.43 73,175 1,275,440 2,511,265 Jun 26 08:45 AM Mosseri Marlio Charles 10% Owner Jun 22 Buy 17.73 6,999 124,092 2,438,090 Jun 23 08:59 AM Mosseri Marlio Charles 10% Owner Jun 21 Buy 17.71 6,091 107,872 2,431,091 Jun 23 08:59 AM BENTSUR RON Chairman & CEO Jun 21 Buy 17.88 500 8,940 3,230,029 Jun 22 08:42 AM Mosseri Marlio Charles 10% Owner Jun 16 Buy 17.75 12,700 225,425 2,425,000 Jun 20 08:25 AM Mosseri Marlio Charles 10% Owner Jun 15 Buy 17.71 32,124 568,848 2,412,300 Jun 16 06:46 AM BENTSUR RON Chairman & CEO Jun 08 Buy 17.53 120 2,104 3,229,529 Jun 08 09:28 PM BENTSUR RON Chairman & CEO Jun 07 Buy 17.41 230 4,004 3,229,409 Jun 08 09:28 PM BENTSUR RON Chairman & CEO May 31 Buy 17.28 330 5,702 3,229,179 Jun 01 08:00 AM BENTSUR RON Chairman & CEO May 24 Buy 17.49 200 3,498 3,228,849 May 26 09:29 AM BENTSUR RON Chairman & CEO May 16 Buy 17.02 320 5,448 3,228,649 May 18 07:00 AM Poradosu Enrique Chief Science & Business Off Mar 27 Buy 11.55 500 5,775 1,373,819 Mar 28 08:30 AM BENTSUR RON Chairman & CEO Mar 23 Buy 12.13 230 2,790 3,228,329 Mar 27 08:21 AM BENTSUR RON Chairman & CEO Mar 21 Buy 12.08 480 5,798 3,228,099 Mar 23 08:30 AM Shemesh Shay Chief Dev. & Ops. Officer Mar 21 Buy 11.99 420 5,036 1,361,955 Mar 22 08:30 AM Shemesh Shay Chief Dev. & Ops. Officer Mar 15 Buy 10.71 670 7,176 1,361,535 Mar 17 08:31 AM BENTSUR RON Chairman & CEO Mar 15 Buy 10.91 480 5,237 3,227,619 Mar 16 04:45 PM BENTSUR RON Chairman & CEO Mar 14 Buy 10.85 1,680 18,228 3,227,139 Mar 16 04:45 PM Shemesh Shay Chief Dev. & Ops. Officer Dec 21 Buy 7.65 500 3,825 1,245,865 Dec 22 08:30 AM
Index RUT
P/E -
EPS (ttm) -2.04
Insider Own 19.49%
Shs Outstand 30.74M
Perf Week -11.75%
Market Cap 46.84M
Forward P/E -
EPS next Y -1.77
Insider Trans 6.02%
Shs Float 25.74M
Perf Month -26.75%
Income -63.23M
PEG -
EPS next Q -0.53
Inst Own 29.24%
Short Float / Ratio 10.83% / 8.35
Perf Quarter -53.64%
Sales 0.30M
P/S 156.12
EPS this Y -9.23%
Inst Trans 15.75%
Short Interest 2.79M
Perf Half Y -75.15%
Book/sh 0.81
P/B 1.82
EPS next Y 12.96%
ROA -57.00%
Target Price 12.00
Perf Year -74.91%
Cash/sh 1.37
P/C 1.07
EPS next 5Y -
ROE -92.56%
52W Range 1.17 - 7.74
Perf YTD -77.43%
Dividend -
P/FCF -
EPS past 5Y 9.16%
ROI -150.99%
52W High -81.07%
Beta -0.23
Dividend % -
Quick Ratio 3.66
Sales past 5Y -43.84%
Gross Margin -868.79%
52W Low 25.21%
ATR 0.16
Employees 98
Current Ratio 3.78
Sales Q/Q -
Oper. Margin -20606.38%
RSI (14) 36.91
Volatility 7.06% 10.99%
Optionable Yes
Debt/Eq 0.65
EPS Q/Q -
Profit Margin -21217.79%
Rel Volume 0.70
Prev Close 1.45
Shortable Yes
LT Debt/Eq 0.63
Earnings Nov 13 AMC
Payout -
Avg Volume 333.91K
Price 1.47
Recom 1.00
SMA20 -10.04%
SMA50 -27.05%
SMA200 -64.49%
Volume 233,510
Change 1.38%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-28-23 Initiated
Piper Sandler
Overweight
$10
Jun-15-23 Initiated
BTIG Research
Buy
$15
Apr-28-21 Initiated
Truist
Buy
$12
Oct-22-19 Initiated
Oppenheimer
Outperform
$9
Nov-15-23 04:05PM
Nov-14-23 10:00AM
Nov-13-23 04:05PM
Nov-03-23 12:00PM
Oct-19-23 04:05PM
04:05PM
Loading…
Oct-17-23 04:05PM
07:30AM
Oct-16-23 07:30AM
07:00AM
Oct-04-23 07:30AM
Oct-02-23 04:05PM
Sep-27-23 09:00AM
Sep-18-23 04:05PM
Sep-07-23 07:30AM
Sep-06-23 07:00AM
04:05PM
Loading…
Aug-10-23 04:05PM
Aug-08-23 09:55AM
Aug-07-23 04:05PM
Aug-01-23 04:05PM
Jul-28-23 10:13AM
Jul-24-23 04:05PM
Jun-22-23 04:05PM
Jun-15-23 04:10PM
04:05PM
Jun-09-23 06:34AM
Jun-08-23 06:43AM
Jun-07-23 08:25AM
Jun-06-23 06:34AM
Jun-05-23 06:44AM
Jun-02-23 06:56AM
06:29AM
Loading…
Jun-01-23 06:29AM
May-31-23 06:40AM
May-30-23 06:50AM
May-26-23 06:59AM
May-25-23 06:38AM
May-24-23 06:43AM
May-23-23 06:33AM
May-22-23 07:49AM
May-19-23 07:03AM
May-18-23 06:39AM
May-17-23 06:35AM
May-16-23 04:05PM
Apr-19-23 09:00AM
Mar-31-23 06:36AM
Mar-23-23 04:05PM
Mar-14-23 04:35PM
Mar-10-23 07:04AM
Feb-22-23 07:00AM
Feb-09-23 04:05PM
Jan-30-23 07:00AM
Jan-24-23 04:05PM
Jan-17-23 04:05PM
Dec-13-22 09:25AM
Nov-17-22 04:05PM
Nov-10-22 09:00AM
Nov-08-22 04:05PM
Oct-24-22 07:30AM
Oct-20-22 04:05PM
Oct-17-22 04:05PM
Oct-05-22 08:00AM
Oct-03-22 07:30AM
Sep-16-22 04:05PM
Aug-23-22 08:00AM
Aug-11-22 04:05PM
Jul-27-22 04:05PM
Jun-28-22 04:10PM
04:05PM
Jun-14-22 04:30PM
Jun-01-22 07:00AM
May-17-22 04:05PM
07:00AM
May-16-22 07:05AM
May-06-22 06:29AM
Apr-25-22 04:05PM
07:00AM
Apr-18-22 07:00AM
Apr-11-22 07:00AM
Mar-08-22 04:35PM
Feb-22-22 04:52AM
Feb-10-22 04:05PM
Feb-08-22 08:00AM
Feb-03-22 04:05PM
Jan-27-22 08:00AM
Dec-14-21 09:15AM
Dec-10-21 09:14AM
Dec-09-21 08:30AM
05:56AM
Dec-01-21 08:00AM
Nov-18-21 04:05PM
Nov-11-21 04:05PM
Nov-04-21 03:01PM
07:30AM
Nov-02-21 08:00AM
Oct-25-21 08:00AM
Oct-20-21 08:00AM
Sep-21-21 04:30PM
Sep-14-21 07:30AM
Aug-25-21 03:55PM
Aug-20-21 04:15PM
Aug-10-21 04:05PM
Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in developing a platform for nitric oxide generators and delivery systems. It operates through the Beyond Air and Beyond Cancer segments. The company was founded on April 28, 2015 and is headquartered in Garden City, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Gaul Michael A. Chief Operating Officer Nov 16 Buy 1.77 10,000 17,700 88,150 Nov 17 04:15 PM Carey Robert Director Aug 28 Buy 2.69 250,000 673,750 1,225,160 Aug 29 04:10 PM Carey Robert Director Aug 21 Buy 2.76 75,050 207,453 975,160 Aug 22 04:10 PM Carey Robert Director Aug 18 Buy 2.64 13,614 35,940 900,110 Aug 22 04:10 PM Gaul Michael A. Chief Operating Officer Jun 30 Buy 4.51 5,000 22,550 78,150 Jul 05 04:05 PM Forbes William P Director Mar 31 Buy 6.67 5,000 33,350 14,855 Apr 03 04:15 PM Carey Robert Director Mar 30 Buy 6.45 10,000 64,500 886,496 Mar 30 06:39 PM Carey Robert Director Mar 29 Buy 6.30 10,000 63,000 876,496 Mar 30 06:39 PM Lee Yoori Director Mar 28 Buy 6.34 3,115 19,749 12,654 Mar 29 05:47 PM Gaul Michael A. Chief Operating Officer Mar 24 Buy 6.15 1,000 6,150 73,150 Mar 27 04:05 PM BENTSUR RON Director Mar 20 Buy 6.48 2,300 14,904 144,736 Mar 21 04:05 PM Lisi Steven A. CEO and Chairman of the Board Mar 17 Buy 6.46 10,000 64,600 1,458,696 Mar 21 04:05 PM Forbes William P Director Mar 17 Buy 6.46 5,000 32,300 9,855 Mar 20 04:05 PM Lucera Erick Director Mar 16 Buy 6.82 2,000 13,634 4,342 Mar 20 04:10 PM Carey Robert Director Mar 14 Buy 6.85 10,000 68,500 866,496 Mar 15 04:05 PM Carey Robert Director Mar 13 Buy 6.15 4,173 25,664 856,496 Mar 15 04:05 PM Avniel Amir Chief Business Officer Mar 13 Buy 6.40 1,000 6,400 457,027 Mar 15 04:05 PM Carey Robert Director Mar 08 Buy 5.95 10,000 59,500 852,323 Mar 09 04:05 PM Lisi Steven A. CEO and Chairman of the Board Mar 08 Buy 5.89 5,000 29,435 1,447,849 Mar 09 04:05 PM Lisi Steven A. CEO and Chairman of the Board Mar 07 Buy 5.98 45,000 268,920 1,442,849 Mar 09 04:05 PM Gaul Michael A. Chief Operating Officer Mar 07 Buy 5.86 8,000 46,880 72,150 Mar 09 04:05 PM Lisi Steven A. CEO and Chairman of the Board Feb 16 Sale 6.10 48,596 296,436 1,397,849 Feb 17 04:30 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite